InVitro International (IVRO)
USD 0.1
(15.93%)
USD 0.1
(15.93%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -313.14 Thousand USD | 74.59% |
| 2022 | -1.23 Million USD | -193.08% |
| 2021 | -420.53 Thousand USD | -54.45% |
| 2020 | -272.27 Thousand USD | 17.56% |
| 2019 | -330.25 Thousand USD | -18.16% |
| 2018 | -279.49 Thousand USD | 34.04% |
| 2017 | -423.72 Thousand USD | -2.13% |
| 2016 | -414.89 Thousand USD | -66.04% |
| 2015 | -249.87 Thousand USD | 0.0% |
| 1996 | -1.2 Million USD | 0.0% |
| 1995 | -1.2 Million USD | 58.62% |
| 1994 | -2.9 Million USD | -3.57% |
| 1993 | -2.8 Million USD | -2700.0% |
| 1992 | -100 Thousand USD | 90.91% |
| 1991 | -1.1 Million USD | -257.14% |
| 1990 | 700 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -362.56 Thousand USD | -15.78% |
| 2024 Q3 | -430.07 Thousand USD | -6.0% |
| 2024 Q2 | -405.73 Thousand USD | -11.91% |
| 2023 Q2 | -712.13 Thousand USD | 38.92% |
| 2023 FY | -313.14 Thousand USD | 74.59% |
| 2023 Q1 | -1.16 Million USD | 5.39% |
| 2023 Q4 | -313.14 Thousand USD | 14.41% |
| 2023 Q3 | -365.87 Thousand USD | 48.62% |
| 2022 Q2 | -417.85 Thousand USD | 15.85% |
| 2022 FY | -1.23 Million USD | -193.08% |
| 2022 Q4 | -1.23 Million USD | -5.76% |
| 2022 Q1 | -496.55 Thousand USD | -18.08% |
| 2022 Q3 | -1.16 Million USD | -178.87% |
| 2021 Q2 | -367.69 Thousand USD | 0.0% |
| 2021 FY | -420.53 Thousand USD | -54.45% |
| 2021 Q4 | -420.53 Thousand USD | 41.25% |
| 2021 Q3 | -715.85 Thousand USD | -94.68% |
| 2020 FY | -272.27 Thousand USD | 17.56% |
| 2019 FY | -330.25 Thousand USD | -18.16% |
| 2018 FY | -279.49 Thousand USD | 34.04% |
| 2017 FY | -423.72 Thousand USD | -2.13% |
| 2016 FY | -414.89 Thousand USD | -66.04% |
| 2015 FY | -249.87 Thousand USD | 0.0% |
| 1997 Q3 | -169 Thousand USD | 55.87% |
| 1997 Q2 | -383 Thousand USD | 0.0% |
| 1996 Q4 | -1.2 Million USD | 29.41% |
| 1996 FY | -1.2 Million USD | 0.0% |
| 1996 Q3 | -1.7 Million USD | -41.67% |
| 1996 Q1 | -700 Thousand USD | 41.67% |
| 1996 Q2 | -1.2 Million USD | -71.43% |
| 1995 Q4 | -1.2 Million USD | 0.0% |
| 1995 FY | -1.2 Million USD | 58.62% |
| 1994 Q3 | -3.4 Million USD | 45.16% |
| 1994 FY | -2.9 Million USD | -3.57% |
| 1994 Q4 | -2.9 Million USD | 14.71% |
| 1994 Q2 | -6.2 Million USD | 12.68% |
| 1994 Q1 | -7.1 Million USD | -153.57% |
| 1993 Q4 | -2.8 Million USD | -86.67% |
| 1993 Q2 | 900 Thousand USD | 350.0% |
| 1993 Q1 | 200 Thousand USD | 300.0% |
| 1993 Q3 | -1.5 Million USD | -266.67% |
| 1993 FY | -2.8 Million USD | -2700.0% |
| 1992 Q2 | -600 Thousand USD | 0.0% |
| 1992 FY | -100 Thousand USD | 90.91% |
| 1992 Q3 | -100 Thousand USD | 83.33% |
| 1992 Q4 | -100 Thousand USD | 0.0% |
| 1991 Q3 | -6 Million USD | -957.14% |
| 1991 Q2 | 700 Thousand USD | 0.0% |
| 1991 Q4 | -1.4 Million USD | 76.67% |
| 1991 FY | -1.1 Million USD | -257.14% |
| 1990 FY | 700 Thousand USD | 0.0% |
| 1990 Q2 | -100 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | 114.195% |
| Arrayit Corporation | 1.05 Million USD | 129.665% |
| Atlantic International Corp. | 236.49 Thousand USD | 232.409% |
| Biocept, Inc. | -788 Thousand USD | 60.261% |
| Bioqual, Inc. | -12 Million USD | 97.392% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | 1477.114% |
| DermTech, Inc. | 17.65 Million USD | 101.774% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 99.945% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 95.755% |
| iMD Companies, Inc. | 1.11 Million USD | 128.061% |
| IDenta Corp. | 524.85 Thousand USD | 159.663% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 104.07% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | -1061.851% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | 119.997% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | -43818.934% |
| Medical Imaging Corp. | 3.79 Million USD | 108.26% |
| NovelStem International Corp. | 3.52 Million USD | 108.892% |
| Optigenex Inc. | 8.93 Million USD | 103.505% |
| PharmChem, Inc. | -1.49 Million USD | 79.046% |
| Proteome Sciences plc | 14.57 Million USD | 102.149% |
| Response Genetics, Inc | -13.08 Million USD | 97.607% |
| Rennova Health, Inc. | 14.82 Million USD | 102.112% |
| RushNet, Inc. | 4.8 Million USD | 106.523% |
| ScreenPro Security Inc. | 135.58 Thousand USD | 330.949% |
| Stella Diagnostics Inc. | 6.19 Million USD | 105.056% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | 117.549% |
| Todos Medical Ltd. | 38.31 Million USD | 100.817% |